Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially. Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome Justyna Domienik-Karłowicz *, Karolina Kupczyńska *, Błażej Michalski , Agnieszka Kapłon-Cieślicka , Szymon Darocha , Piotr Dobrowolski , Maciej Wybraniec , Wojciech Wańha , Miłosz J. Jaguszewski 9

[1]  H. Thiele,et al.  Lesson learnt from the new 2020 ESC guidelines on non-ST-segment elevation acute coronary syndrome: when clinical judgement precedes and overpasses weak recommendations. 2020 non-ST-segment elevation acute coronary syndrome guidelines on pre-treatment: primum non nocere! , 2020, European heart journal.

[2]  Z. Siudak,et al.  Clinical and procedural characteristics of COVID‐19 patients treated with percutaneous coronary interventions , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  R. Manka,et al.  Impact of a nationwide COVID-19 lockdown on acute coronary syndrome referrals. , 2020, Cardiology journal.

[4]  Jeroen J. Bax,et al.  Coexistence and outcome of coronary artery disease in Takotsubo syndrome. , 2020, European heart journal.

[5]  G. Niccoli,et al.  Decreased myocardial infarction admissions during COVID times: what can we learn? , 2020, Cardiovascular research.

[6]  O. Rodriguez-Leor,et al.  STEMI care during COVID-19: losing sight of the forest for the trees , 2020, JACC: Case Reports.

[7]  C. Schmidt,et al.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[8]  K. Thygesen.  'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018. , 2019, European heart journal.

[9]  Marco Valgimigli,et al.  [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.] , 2018, Kardiologia polska.

[10]  J. Januzzi,et al.  The Many Faces of Type 2 Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[11]  K. Thygesen,et al.  Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice. , 2017, The American journal of medicine.

[12]  K. Thygesen,et al.  Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions. , 2016, The American journal of medicine.

[13]  D. Atar,et al.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. , 2016, European heart journal.

[14]  G. Schaaf,et al.  Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease , 2016, Circulation. Cardiovascular genetics.

[15]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. , 2015, Revista espanola de cardiologia.

[16]  Jeroen J. Bax,et al.  Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. , 2015, The New England journal of medicine.

[17]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[18]  B. Lecky,et al.  Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction. , 2014, Journal of the American College of Cardiology.

[19]  J. Alpert,et al.  How to use high-sensitivity cardiac troponins in acute cardiac care. , 2013, European heart journal.

[20]  P. Moreno,et al.  Angiographic investigation of the pathophysiology of perioperative myocardial infarction , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[21]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[22]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[23]  Jeroen J. Bax,et al.  ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation , 2012 .

[24]  A. Jaffe,et al.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. , 2011, Journal of the American College of Cardiology.

[25]  D. Xavier,et al.  High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. , 2011, Clinical biochemistry.

[26]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[27]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[28]  S. Darby,et al.  Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study , 2009, Heart.

[29]  D. Dudek,et al.  Myocardial infarction in the shadow of COVID-19. , 2020, Cardiology journal.

[30]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .